Dharmisha Chauhan

An immunotherapy survivor population: health-related quality of life and toxicity in patients with metastatic melanoma treated with immune checkpoint inhibitors

J. Larkin, M. Gore, K. Edmonds, 2019, Supportive Care in Cancer.

Prognostic score for patients with advanced melanoma treated with ipilimumab.

J. Larkin, M. Gore, B. Kasenda, 2015, European journal of cancer.

Five-year review of corticosteroid duration and complications in the management of immune checkpoint inhibitor-related diarrhoea and colitis in advanced melanoma

J. Larkin, S. Turajlic, L. Au, 2020, ESMO Open.

Clinical outcomes of patients with corticosteroid refractory immune checkpoint inhibitor-induced enterocolitis treated with infliximab

Bhavisha P. Sheth, L. Pickering, R. Ratnakumaran, 2021, Journal for ImmunoTherapy of Cancer.

Toxicity management of regorafenib in patients with gastro-intestinal stromal tumour (GIST) in a tertiary cancer centre

Robin L. Jones, C. Fisher, B. Engelmann, 2020, Clinical Sarcoma Research.

Poor treatment outcomes with palliative gemcitabine and docetaxel chemotherapy in advanced and metastatic synovial sarcoma

Robin L. Jones, C. Fisher, I. Judson, 2018, Medical Oncology.

Management of early melanoma recurrence despite adjuvant anti-PD-1 antibody therapy.

R. Dummer, S. Patel, C. Blank, 2020, Annals of oncology : official journal of the European Society for Medical Oncology.